Panacea Life Sciences Holdings, Inc., based in Golden, Colorado, has recently announced its adoption of a diversification plan to cater to the growing demand for natural health and wellness products.
As a plant-based natural health ingredient and product company, Panacea intends to expand its focus to include a range of offerings.
Recognizing the surge of interest in therapeutic plant-based products within the health and wellness domain, both among consumers and the medical and scientific communities, Panacea aims to capitalize on this trend. The company plans to broaden its portfolio by incorporating Kratom and Kava, and also explore potential acquisitions of natural and organic-based products in the natural health and wellness sector. This expansion includes the introduction of non-alcoholic health and energy drinks, and vaping products, as well as conducting investigative research on substances like Psylocibin and other psychedelics for potential health benefits. Panacea will continue manufacturing its existing product lines, which include CBD/CBG and vegan soft gel caps, both under its brand and as a contract manufacturer for other companies, utilizing its 51,000 sq. ft. cGMP facility in Golden, Colorado.
Panacea Life Sciences Holdings, Inc. is a holding company primarily focused on facilitating the development, manufacturing, research, product development, and distribution within the thriving market segment of natural human and animal health and wellness. Its subsidiary, Panacea Life Sciences, Inc., is a woman-founded and led company dedicated to producing the highest-quality nutraceutical, cannabinoid, mushroom, kratom, and other natural plant-based ingredients and products. Operating out of a state-of-the-art 51,000-square-foot cGMP facility in Golden, Colorado, Panacea Life Sciences strives to excel in its commitment to quality.
It’s important to note that this press release contains forward-looking statements subject to risks and uncertainties that could cause actual results to differ from the projected or anticipated outcomes. Factors such as supply chain disruptions, the ability to obtain raw materials, customer returns, and the impact of the pandemic, among others, may affect the company’s operations. Panacea Life Sciences Holdings, Inc. undertakes no obligation to update any forward-looking statements unless required by law publicly.
For more information about Panacea Life Sciences Holdings, Inc., please visit their website at www.panacealife.com.
